PTC is committed to bringing hope to patients with rare and genetic diseases.
Our scientists are finding new ways to regulate biology to control disease.
We are developing new treatments for Duchenne Muscular Dystrophy, Cystic Fibrosis and other diseases.
About PTC Clinical Trials Careers at PTC
PTC Announces Translarna™ Access Program In Duchenne Muscular Dystrophy For Siblings Of Patients Participating In PTC Clinical Trials
PTC Therapeutics Reports Fourth Quarter And 2014 Full Year Financial Results And Provides Corporate Update
PTC Therapeutics To Participate At Upcoming March Investor Conferences
View all latest news